24小时热门版块排行榜    

查看: 661  |  回复: 1
本帖产生 1 个 LS-EPI ,点击这里进行查看

babyqiqi

禁虫 (正式写手)

本帖内容被屏蔽

已阅   关注TA 给TA发消息 送TA红花 TA的回帖

gruyclewee

荣誉版主 (文坛精英)

优秀版主优秀版主优秀版主

【答案】应助回帖

★ ★ ★ ★ ★ ★ ★ ★ ★ ★
感谢参与,应助指数 +1
babyqiqi: 金币+10, ★★★★★最佳答案 2014-08-01 07:53:04
oven1986: 检索EPI+1, 感谢应助! 2014-08-01 10:18:29
作者: Cao, S (Cao, Shuang); Zhou, XB (Zhou, Xin-Bo); Zhang, H (Zhang, Heng); Li, S (Li, Song); Zhong, W (Zhong, Wu)
标题: Novel cross-link breaker based on zwitterion structure: Synthesis, structure and druggability studies
来源出版物: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷: 68
页: 89-95
DOI: 10.1016/j.ejmech.2013.07.033
出版年: OCT 2013
摘要: It has been universally acknowledged that the increase in cardiac and vascular stiffness is due to the formation of advanced glycosylation end-products (AGEs). Research on the stable form of 3-(carboxymethyl)-4-methylthiazol bromide sodium salt (C6H7BrNNaO2S) showed that it had a notable effect on breaking the AGEs. Two compounds with novel structures, zwitterionic 3-(carboxymethyl)-4-methylthiazol (C6H7O2NS) and a dipolymer (C12H15O4N2S2Br) complex, were obtained. When compared with the forms of sodium salt and dipolymer, zwitterion had an obvious advantage in stability, solubility, synthesis and pH, which made the zwitterion a promising drug. The structure of sodium salt, dipolymer and zwitterion was comparatively analyzed by such methods as single crystal X-ray diffraction, ESI-MS, H-1 NMR, FT-IR and in situ IR. (C) 2013 The Authors. Published by Elsevier Masson SAS. All rights reserved.
Web of Science 核心合集中的 "被引频次": 0
在 BIOSIS Citation Index 中的被引频次: 0
在中国科学引文数据库中的被引频次: 0
SciELO Citation Index 中的 "被引频次": 0
被引频次合计: 0
ISSN: 0223-5234; 1768-3254
入藏号: WOS:000326902300010
竹杖芒鞋轻胜马,一蓑烟雨任平生。
2楼2014-07-30 23:41:50
已阅   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 babyqiqi 的主题更新
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[教师之家] 为了不被淘汰,必须要开始第三次奋斗了 +7 lice_1987 2026-11-15 9/450 2026-11-19 09:30 by 青蒿素888
[教师之家] 征友后感触 +6 重新启 2026-11-17 7/350 2026-11-19 08:12 by m_zyj
[论文投稿] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +5 XJXMuRjD7cK7 2026-11-13 5/250 2026-11-19 00:17 by Equinoxhua
[考博] 27博士申请(市政/环境) +4 ladf 2026-11-12 4/200 2026-11-18 20:18 by junqiang
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 SX5mJmPWDfOO 2026-11-13 4/200 2026-11-18 13:55 by UPDUsNlULsJZ
[论文投稿] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +5 SX5mJmPWDfOO 2026-11-13 5/250 2026-11-18 13:44 by UPDUsNlULsJZ
[考博] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +5 XJXMuRjD7cK7 2026-11-13 5/250 2026-11-18 13:22 by UPDUsNlULsJZ
[论文投稿] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +5 XJXMuRjD7cK7 2026-11-13 5/250 2026-11-18 11:43 by Z1pODz48hoDV
[硕博家园] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +5 XJXMuRjD7cK7 2026-11-13 5/250 2026-11-18 11:32 by Z1pODz48hoDV
[考博] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 uKOSCocCb6Fm 2026-11-13 4/200 2026-11-18 10:37 by Z1pODz48hoDV
[论文投稿] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +3 uKOSCocCb6Fm 2026-11-13 4/200 2026-11-18 10:04 by Z1pODz48hoDV
[考研] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +4 uKOSCocCb6Fm 2026-11-12 6/300 2026-11-18 09:31 by Z1pODz48hoDV
[论文投稿] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +5 uKOSCocCb6Fm 2026-11-12 8/400 2026-11-18 09:20 by Z1pODz48hoDV
[硕博家园] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +4 uKOSCocCb6Fm 2026-11-12 7/350 2026-11-18 09:09 by Z1pODz48hoDV
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 uKOSCocCb6Fm 2026-11-12 9/450 2026-11-18 09:06 by Equinoxhua
[公派出国] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +4 uKOSCocCb6Fm 2026-11-12 8/400 2026-11-18 08:58 by Z1pODz48hoDV
[考博] 27年药学 考博申请 +4 。12345 2026-11-14 5/250 2026-11-16 19:52 by 0611517sll
[考博] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 SX5mJmPWDfOO 2026-11-13 3/150 2026-11-15 08:18 by xSrQNSSjcgoX
[硕博家园] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +4 XJXMuRjD7cK7 2026-11-13 4/200 2026-11-15 06:50 by xSrQNSSjcgoX
[考博] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +3 uKOSCocCb6Fm 2026-11-12 7/350 2026-11-15 03:32 by xSrQNSSjcgoX
信息提示
请填处理意见